AVITA Medical Inc

RCELNASDAQ · USD
11.02USD0.00 (-1.79%)
2410

AVITA Medical Inc (RCEL) Options Open Interest

RCEL options open interest is 4,398 contracts. The 2-week average daily volume is 399 contracts across the chain.

Read more

Monitoring RCEL open interest helps you see where real money is positioned on AVITA Medical Inc's options and which strikes are attracting the most commitment from traders. AVITA Medical Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor RCEL options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising RCEL options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect AVITA Medical Inc to settle.

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older.

The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where RCEL open interest is concentrated. Our scanner maps AVITA Medical Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade AVITA Medical Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
15.000.100.1079%+0.0969819
12.500.600.6093%+0.3602162
5.005.206.906.05135%+0.9902125
7.503.104.303.70117%+0.914962
10.001.202.701.95120%+0.680747
Puts
5.000.750.75349%-0.0953105
7.500.750.75209%-0.167450
10.000.150.600.3869%-0.266733
2.500.500.50527%-0.039825
17.505.607.406.50100%-0.93901

As of September 18, 2026

Follow the money

Track RCEL open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial